Concepedia

Paul Rolzin

PR

Statistics

Publications

4

Citations

233

H-Index

4

Active since

2010

Affiliations

Takeda (Japan)(Current)

Takeda (United States)

Paul Rolzin is an author at Takeda (Japan) specializing in biochemistry, life sciences, and growth factor therapy.

Publications per year

2010–2019

4

Publications

4

Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody

Jie Huang, Tetsuya Ishino, Gang Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 118 citations

, , +17

A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis

Jorge Gomez‐Galeno, Qun Dang, Thanh H. Nguyen et al. · ACS Medicinal Chemistry Letters · 2010 · 91 citations

, , +16

MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes

Huey-Jing Huang, Corine Holub, Paul Rolzin et al. · Journal of Biological Chemistry · 2019 · 14 citations · Full text

, , +17

Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors

Pamela Farrell, Christopher J. Zopf, Huey-Jing Huang et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 10 citations · Full text

, , +16

1–4 of 4